<DOC>
	<DOC>NCT00309491</DOC>
	<brief_summary>Primarily, this clinical investigation compared the efficacy of tamoxifen + aminoglutethimide vs. tamoxifen alone in terms of prognosis (overall survival) in postmenopausal patients with potentially curative, operated hormone receptor-positive breast cancer.</brief_summary>
	<brief_title>Randomized Study Comparing Tamoxifen vs. Tamoxifen + Aminoglutethimide in Postmenopausal Receptor-positive Patients</brief_title>
	<detailed_description />
	<mesh_term>Tamoxifen</mesh_term>
	<mesh_term>Aminoglutethimide</mesh_term>
	<criteria>Postmenopausal patients with histologically verified, locoradically treated, invasive or minimally invasive breast cancer Hormone receptorpositive status More than 6 histologically examined lymph nodes Laboratory parameters 1. hematopoiesis: &gt; 3500/µl leucocytes, &gt; 100,000/µl thrombocytes 2. renal function: creatinin &lt; 1.5mg% 3. hepatic function: GOT &lt; 2.5 x UNL 4. bilirubin: &lt; 1.5mg % 5. metabolic parameters: Na, Ca, K in normal range, normal level of blood sugar Concluded healing process following surgery Less than 4 weeks interval since surgery Informed consent Premenopausal patients, nondeterminable menopausal status Previous radiotherapy, chemotherapy or endocrine treatment Generalized disease (as verified by lung Xray, skeletal Xray, liver ultrasound) Contraindications against tamoxifen or anastrozole T4 tumors; carcinoma in situ Lacking compliance or understanding of disease Karnofsky Index &lt; 3 Serious concomitant disease Septic complications, systemic infections or infectious local processes Bilateral ovariectomy or ovarian irradiation Second carcinoma or status post second carcinoma (except for treated squamous cell carcinoma of the skin or cervical carcinoma in situ)</criteria>
	<gender>Female</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Tamoxifen</keyword>
	<keyword>Aminoglutethimide</keyword>
	<keyword>Breast cancer</keyword>
</DOC>